Mayo Clinic Study Finds Heart Transplant Patients Benefit from New Approach to Immunosuppression

ROCHESTER, Minn. -- A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at The International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco.

>>> Discuss This Story

Back to news